Optimizing Clinical use of polymyxin B: teaching an old drug to treat superbugs

Li, Jian (Primary Chief Investigator (PCI))
Nation, Roger (Chief Investigator (CI))
Purcell, Anthony (Chief Investigator (CI))

Project: Research

Project Description

Human - Pending

Status	Finished
Effective start/end date	19/06/15 → 31/05/22

Funding

National Institutes of Health (United States): A$1,962,852.00

1 Article

International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)
Tsuji, B. T., Pogue, J. M., Zavascki, A. P., Paul, M., Daikos, G. L., Forrest, A., Giacobbe, D. R., Viscoli, C., Giamarellou, H., Karaiskos, I., Kaye, D., Mouton, J. W., Tam, V. H., Thamlikitkul, V., Wunderink, R. G., Li, J., Nation, R. L. & Kaye, K. S., Jan 2019, In: Pharmacotherapy. 39, 1, p. 10-39 30 p.
Research output: Contribution to journal › Article › Other › peer-review

Open Access
File

343 Citations (Scopus)